| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $537K | -39.9% |
| Cost of Revenue | $147K | -53.8% |
| Gross Profit | $390K | -32.2% |
| R&D Expense | $4.9M | -14.2% |
| SG&A Expense | $5.1M | -23.2% |
| Operating Income | -$16.1M | +14.0% |
| Pre-tax Income | -$16.2M | +24.9% |
| Net Income | -$16.2M | +24.9% |
| EPS (Basic) | -$2.70 | +87.7% |
| EPS (Diluted) | -$2.70 | +87.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $17K | -48.3% |
| Inventory | $217K | -41.8% |
| Current Assets | $1.8M | -77.0% |
| Total Assets | $5.3M | -60.5% |
| Current Liabilities | $3.7M | -40.3% |
| Total Liabilities | $4.7M | -37.6% |
| Stockholders' Equity | $642K | -89.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$11.0M | +36.6% |
| Capital Expenditures | $1K | -98.8% |
| Investing Cash Flow | -$1.0M | -419.8% |
| Financing Cash Flow | $6.8M | -59.7% |
| Free Cash Flow | -$11.0M | +37.0% |